Isoflurane preconditioning reduces the rat NR8383 macrophage injury induced by lipopolysaccharide and interferon γ

Anesthesiology

Volumn 108, Issue 4, 2008, Pages 643-650

  Xu, Xuebing ^a,b   Feng, Jifeng ^a,c   Zuo, Zhiyi ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Department of Anesthesiology   (China)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ISOFLURANE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROPIDIUM IODIDE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; ISCHEMIC PRECONDITIONING; MACROPHAGE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 41149122004     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318167aeb4     Document Type: Article

References (39)

1. Nathan CF: Neutrophil activation on biological surfaces: Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80:1550-60
2. Aderem A: Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med 2001; 29:S16-8
3. Zychlinsky A, Sansonetti P: Perspectives series: Host/pathogen interactions. Apoptosis in bacterial pathogenesis. J Clin Invest 1997; 100:493-5
4. Williams TE, Ayala A, Chaudry IH: Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release. J Surg Res 1997; 70:113-8
5. Ayala A, Urbanich MA, Herdon CD, Chaudry IH: Is sepsis-induced apoptosis associated with macrophage dysfunction? J Trauma 1996; 40:568-73
6. Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K, Standiford TJ: Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin 10. Infect Immun 2001; 69:1394-401
7. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, Flavell RA, Standiford TJ: Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 2006; 116:2532-42
8. Lasbury ME, Durant PJ, Ray CA, Tschang D, Schwendener R, Lee CH: Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J Immunol 2006; 176:6443-53
9. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR: Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 2000; 278:L840-7
10. Tobias PS, Mathison JC, Ulevitch RJ: A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 1988; 263:13479-81
11. Fuentes JM, Talamini MA, Fulton WB, Hanly EJ, Aurora AR, De Maio A: General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock. Clin Vaccine Immunol 2006; 13:281-8
12. Reutershan J, Chang D, Hayes JK, Ley K: Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. ANESTHESIOLOGY 2006; 104: 511-7
13. Zhuang JC, Wogan GN: Growth and viability of macrophages continuously stimulated to produce nitric oxide. Proc Natl Acad Sci USA 1997; 94:11875-80
14. Lopez-Collazo E, Hortelano S, Bosca L: Interferon-alpha/beta inhibits the apoptosis induced by lipopolysaccharide and interferon-gamma in murine peritoneal macrophages. J Interferon Cytokine Res 1998; 18:461-7
15. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150:5080-5
16. Bosca L, Zeini M, Traves PG, Hortelano S: Nitric oxide and cell viability in inflammatory cells: A role for NO in macrophage function and fate. Toxicology 2005; 208:249-58
17. Fuentes JM, Hanly EJ, Aurora A, De Maio A, Talamini MA: Anesthesia-specific protection from endotoxic shock is not mediated through the vagus nerve. Surgery 2005; 138:766-71
18. Plachinta RV, Hayes JK, Cerilli LA, Rich GF: Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. A NESTHESIOLOGY 2003; 98: 89-95
19. Giraud O, Seince PF, Rolland C, Lecon-Malas V, Desmonts JM, Aubier M, Dehoux M: Halothane reduces the early lipopolysaccharide-induced lung inflammation in mechanically ventilated rats. Am J Respir Crit Care Med 2000; 162: 2278-86
20. Lipton P: Ischemic cell death in brain neurons. Physiol. Rev 1999; 79: 1431-568
21. Barone FC, Tuma RF, Legos JJ, Erhardt JA, Parsons AA: Brain Inflammation, Cytokines, and p38 MAP Kinase Signaling in Stroke. Edited by Lin RCS. Boca Raton, CRC, 2002, pp 204-44
22. Zheng S, Zuo Z: Isoflurane preconditioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinase. Mol Pharmacol 2004; 65:1172-80
23. Zheng S, Zuo Z: Isoflurane preconditioning decreases glutamate receptor overactivation-induced Purkinje neuronal injury in rat cerebellar slices. Brain Res 2005; 1054:143-51
24. Zheng S, Zuo Z: Isoflurane preconditioning reduces Purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003; 118:99-106
25. Raphael J, Abedat S, Rivo J, Meir K, Beeri R, Pugatsch T, Zuo Z, Gozal Y: Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006; 318:186-94
26. de Klaver MJM, Manning L, Palmer L, Rich GF: Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. ANESTHESIOLOGY 2002; 97:24-32
27. Huang Y, Zuo Z: Isoflurane enhances the expression and activity of glutamate transporter type 3 in C6 glioma cells. ANESTHESIOLOGY 2003; 99:1346-53
28. Huang Y, Zuo Z: Isoflurane induces a protein kinase C alpha-dependent increase in cell surface protein level and activity of glutamate transporter type 3. Mol Pharmacol 2005; 67:1522-33
29. Zuo Z, Johns RA: Halothane, enflurane, and isoflurane do not affect the basal or agonist-stimulated activity of partially isolated soluble and particulate guanylyl cyclases of rat brain. ANESTHESIOLOGY 1995; 83:395-404
30. Zuo Z, Wang Y, Huang Y: Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006; 542:84-91
31. Zuo Z, Johns RA: Inhalational anesthetics up-regulate constitutive and lipopolysaccharide-induced inducible nitric oxide synthase expression and activity. Mol Pharmacol 1997; 52:606-12
32. Xu Y, Kim SO, Li Y, Han J: Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem 2006; 281:19179-87
33. Hortelano S, Zeini M, Castrillo A, Alvarez AM, Bosca L: Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decrease. Cell Death Differ 2002; 9:643-50
34. Hortelano S, Traves PG, Zeini M, Alvarez AM, Bosca L: Sustained nitric oxide delivery delays nitric oxide-dependent apoptosis in macrophages: Contribution to the physiological function of activated macrophages. J Immunol 2003; 171:6059-64
35. Hemmings HJ, Adamo A, Hoffman M: Biochemical characterization of the stimulatory effects of halothane and propofol on purified brain protein kinase C. Anesth Analg 1995; 81:1216-22
36. Su JY, Vo AC: Role of PKC in isoflurane-induced biphasic contraction in skinned pulmonary arterial strips. ANESTHESIOLOGY 2002; 96:155-61
37. Salonen T, Sareila O, Jalonen U, Kankaanranta H, Tuominen R, Moilanen E: Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages. Br J Pharmacol 2006; 147:790-9
38. Paul A, Doherty K, Plevin R: Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br J Pharmacol 1997; 120:940-6
39. Muhl H, Pfeilschifter J: Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat renal mesangial cells. Biochem J 1994; 303(pt 2):607-12